A culture medium and fermentation method for producing anti-PD-1 antibodies
By optimizing the culture medium composition and culture process of CHO cells, the stability problem of CHO cells in the production of anti-PD-1 monoclonal antibodies was solved, achieving long-term stability of antibody expression and high-quality production, which is suitable for large-scale industrial production.
Patent Information
- Application Number
- CN202510620548.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-14
- Publication Date
- 2026-11-17
AI Technical Summary
CHO cells have stability issues in the production of anti-PD-1 monoclonal antibodies, especially the decline in antibody expression during long-term culture, which affects production efficiency and product quality. Existing DHFR systems have limitations, leading to cell bank instability.
The passage stability of CHO cells was optimized by improving the culture medium composition and culture process, including the use of specific concentrations of MTX, sodium dextran sulfate and uridine, as well as feeding strategies, combined with temperature and pH control in the bioreactor.
It significantly improves the passage stability of CHO cell banks, reduces the accumulation of metabolic byproducts, and ensures the long-term stability of antibody expression levels, making it suitable for large-scale industrial production of high-quality anti-PD-1 monoclonal antibodies.
Smart Images

Figure BDA0005402365900000021 
Figure BDA0005402365900000031 
Figure BDA0005402365900000032
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biotechnology. Specifically, this invention relates to a method for protein expression, and more specifically, to a method for expressing a protein drug in CHO cells. Background Technology
[0002] PD-1 antibody (Programmed cell death protein 1, PD-1) is a new type of anti-tumor monoclonal antibody drug. It can block the binding of PD-1 to its ligand PD-L1, thereby relieving the suppression of immune function mediated by PD-1 / PD-L1 binding, and enabling human T cells to be reactivated to maximize their effect of killing tumor cells.
[0003] Most therapeutic recombinant antibodies use Chinese hamster ovary cells (CHO cells) as the antibody production platform. Using Chinese hamster ovary cells (CHO cells) to produce anti-PD-1 monoclonal antibodies has significant advantages: (1) they are suitable for suspension culture, meeting the needs of large-scale industrial production of recombinant proteins; (2) the antibody molecules expressed by CHO cells are highly similar to natural antibody molecules in structure and function; (3) CHO cells carry a very low risk of human viruses; (4) exogenous genes can be stably integrated and efficiently expressed in CHO cells; (5) as fibroblasts, CHO cells secrete almost no endogenous proteins, which facilitates the isolation and purification of recombinant antibodies. However, when examining the stability of the CHO cell bank used for anti-PD-1 monoclonal antibody production, we found that the antibody expression level in the 60th generation of the working cell bank (WCB) decreased by more than 30% compared to the primary WCB.
[0004] During cell line screening, cell bank stability studies must cover the maximum passage number for future commercial production, typically at least 60 passages. The studies primarily include cell growth characteristics, antibody expression levels, antibody quality, and the genetic stability of the target gene. A stable cell line can be considered stable if antibody yield fluctuations do not exceed 30%, provided antibody quality remains largely unchanged. However, in existing technologies using CHO cells with a dihydrofolate reductase (DHFR) system to produce anti-PD-1 monoclonal antibodies, significant instability was observed in the working cell bank (WCB) during passage passages. Specifically, when examining the passage stability of the WCB cell bank, antibody expression levels at passage 60 were found to be more than 30% lower than in the primary WCB. This instability may stem from the CHO cell expression system, culture conditions, and the accumulation of metabolic byproducts during culture.
[0005] The CHO expression system used in this invention is based on the dihydrofolate reductase (DHFR) gene amplification mechanism, which is one of the most commonly used gene amplification and selection systems. When CHO cells are transfected with an expression plasmid carrying the DHFR gene, the cells can grow in a selective medium containing the folic acid analog amethopterin (MTX). By gradually increasing the MTX concentration, the vast majority of cells die due to intolerance, while in the few surviving resistant cells, the DHFR gene and its adjacent exogenous target gene regions are amplified, with copy numbers increasing hundreds to thousands of times, thereby achieving high-level expression of the target gene and counteracting the inhibitory effect of MTX.
[0006] However, the DHFR system also has certain limitations: (1) it is only applicable to DHFR-deficient cells; (2) the workload of repeated screening for resistant cells is large; (3) after the removal of selection pressure, the amplified genes may become unstable, leading to the loss of exogenous genes or excessive cell proliferation, which in turn causes a decrease in antibody expression. In addition, with the extension of culture time, the stability of CHO cells is also easily affected by factors such as temperature, pH, osmotic pressure and oxygen transfer in the culture environment. These factors will dynamically affect the cell transcriptome, leading to decreased yield, extended production cycle, increased cost, changes in protein quality and potential regulatory compliance issues; at the same time, metabolic byproducts (such as lactic acid and ammonia) accumulated during culture will also have a negative impact on cell stability and product quality.
[0007] The above phenomena reveal the limitations of existing CHO cell expression systems during long-term culture. This instability affects the production efficiency and product quality of anti-PD-1 monoclonal antibodies, and there is an urgent need to improve the stability of cell banks and the sustainability of antibody expression through technological improvements. Summary of the Invention
[0008] This invention addresses the instability of CHO cells using the DHFR system in the production of anti-PD-1 monoclonal antibodies. To resolve this issue, this invention significantly improves the passage stability of the CHO cell bank by optimizing the culture medium and culture process, thereby ensuring the long-term stability of antibody expression levels.
[0009] The first objective of this invention is to provide a culture medium for producing anti-PD-1 antibodies, the culture medium comprising basal culture medium BM1, basal culture medium BM2, basal culture medium BM3 and supplemental culture medium.
[0010] The basal culture medium BM1 contains MTX, sodium dextran sulfate and BM components.
[0011] The basal culture medium BM2 contains MTX, sodium dextran sulfate, uridine, and BM components.
[0012] The basal culture medium BM3 contains sodium dextran sulfate, uridine, and BM components.
[0013] The supplemental culture medium contains uridine and FM components.
[0014] Preferably, the culture medium contains 0.0002-0.0006 mM of MTX.
[0015] Preferably, the culture medium contains 0.05-0.1 mM sodium dextran sulfate.
[0016] Preferably, the culture medium contains 2.0-8.0 mM uridine.
[0017] The BM components are shown in Table 1:
[0018] Table 1 BM Components
[0019]
[0020]
[0021] The components of the basal culture medium BM1 described in this invention are shown in Table 2:
[0022] Table 2. Basal Culture Medium BM1
[0023]
[0024]
[0025] More preferably, the components of the basal culture medium BM1 of the present invention are shown in Table 3:
[0026] Table 3. Basal Culture Medium BM1
[0027] Components Concentration (mM) MTX 0.0005 Sodium dextran sulfate 0.07 BM See Table 1
[0028] The components of the basal culture medium BM2 described in this invention are shown in Table 4:
[0029] Table 4. Basal Culture Medium BM2
[0030] Components Concentration (mM) MTX 0.0002-0.0006 Sodium dextran sulfate 0.05-0.1 Ureidine 2.0-8.0 BM See Table 1
[0031] More preferably, the components of the basal culture medium BM2 of the present invention are shown in Table 5:
[0032] Table 5. Basal Culture Medium BM2
[0033] Components Concentration (mM) MTX 0.0005 Sodium dextran sulfate 0.07 Ureidine 4.8 BM See Table 1
[0034] The components of the basal culture medium BM3 described in this invention are shown in Table 6:
[0035] Table 6. Basal Culture Medium BM3
[0036] Components Concentration (mM) Sodium dextran sulfate 0.05-0.1 Ureidine 2.0-8.0 BM See Table 1
[0037] More preferably, the components of the basal culture medium BM3 of the present invention are shown in Table 7:
[0038] Table 7. Basal Culture Medium BM3
[0039]
[0040]
[0041] The components of the supplemental culture medium described in this invention are shown in Table 8:
[0042] Table 8 Feeding Culture Medium
[0043] Components Concentration (mM) Components Concentration (mM) Ureidine 2.0-8.0 L-proline 28.8 L-Aspartic acid 48 Phosphorylated L-tyrosine 19.2 L-glutamic acid 38.4 L-valine 28.8 L-Asparagine 48 L-methionine 13.44 L-serine 48 S-sulfo-L-cysteine 9.6 L-glutamine 57.6 L-Isoleucine 28.8 L-glycine 2.88 L-Leucine 38.4 L-histidine 9.6 L-phenylalanine 9.6 L-arginine 19.2 L-Tryptophan 19.2 L-threonine 28.8 L-Lysine 38.4 L-alanine 19.2 - -
[0044] More preferably, the components of the supplemental culture medium of the present invention are shown in Table 9:
[0045] Table 9 Feeding Culture Medium
[0046] Components Concentration (mM) Components Concentration (mM) Ureidine 4.8 L-proline 28.8 L-Aspartic acid 48 Phosphorylated L-tyrosine 19.2 L-glutamic acid 38.4 L-valine 28.8 L-Asparagine 48 L-methionine 13.44 L-serine 48 S-sulfo-L-cysteine 9.6 L-glutamine 57.6 L-Isoleucine 28.8 L-glycine 2.88 L-Leucine 38.4 L-histidine 9.6 L-phenylalanine 9.6 L-arginine 19.2 L-Tryptophan 19.2 L-threonine 28.8 L-Lysine 38.4 L-alanine 19.2 - -
[0047] The feed culture media shown in Tables 8 and 9, except for uridine, are denoted as FM components.
[0048] A second objective of this invention is to provide a method for producing anti-PD-1 antibodies, the method comprising the following steps:
[0049] Step 1: Provide CHO cells containing the target gene encoding the anti-PD-1 antibody.
[0050] Step 2: The CHO cells obtained in Step 1 are expanded by shaking flasks.
[0051] Step 3: Cell culture in the bioreactor stage.
[0052] Step 4: End of training and harvest.
[0053] The cells obtained in step one are referred to as WCB primary cells.
[0054] Preferably, the cell shake-flask amplification in step two includes the following stages:
[0055] (1) Cell resuscitation: The cells obtained in step one were resuscitated using basal culture medium BM1.
[0056] (2) Shake flask amplification culture: Shake flask amplification culture was carried out using basal medium BM2.
[0057] Preferably, the cell culture in the bioreactor stage of step three includes the following stages:
[0058] (1) Seed inoculation and initial culture;
[0059] (2) Replenishing materials;
[0060] (3) Optimization of cultivation conditions.
[0061] More preferably, the seed inoculation and initial culture in step three involves inoculating the above-mentioned seed solution into a culture medium for Fed-batch culture.
[0062] More preferably, the feeding in step three is done using a feeding culture medium, and the bioreactor rotation speed is adjusted appropriately.
[0063] More preferably, the optimization of culture conditions in step three involves cooling the bioreactor, strictly controlling the pH, and maintaining the glucose concentration in the culture when the cell density reaches a certain level.
[0064] More preferably, the feeding strategy described in step three is when the cell density reaches 4.0-6.0 × 10⁻⁶. 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using feeding medium. The feeding method is to feed once a day. The first to fourth feedings should be 2% of the culture volume, and thereafter the feeding volume should be increased to 3%.
[0065] More preferably, the bioreactor rotation speed is increased to 420 rpm after the fourth feeding.
[0066] More preferably, when the cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio is reached, the temperature is lowered to 33℃ and the pH is strictly controlled at 7.0±0.05. During the feeding process, glucose solution is used to maintain the glucose concentration in the culture at around 33.3mM.
[0067] The components of each culture medium described in steps two and three are shown in Tables 1 to 9.
[0068] Preferably, in step four, the end of cultivation and harvesting occurs after 15 days of cultivation in the bioreactor, and the culture medium is harvested for subsequent analysis. Sampling and detection frequency: the first sample is taken 24 hours after inoculation to detect relevant indicators, and then samples are taken and tested daily until the end of cultivation.
[0069] More preferably, the method for producing anti-PD-1 antibody according to the present invention includes the following steps:
[0070] Step 1: Provide CHO cells containing the target gene encoding the anti-PD-1 antibody, which can be cryopreserved for later use.
[0071] Step 2: Shake-flask amplification of CHO cells obtained in Step 1
[0072] (1) Cell resuscitation: CHO cells were resuscitated using BM1 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, and BM components (as shown in Table 3).
[0073] (2) Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, 4.8 mM uridine, and BM components (as shown in Table 5). Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0074] Step 3: Cell culture in the bioreactor stage
[0075] (1) Seed inoculation and initial culture: 300 mL of the above seed culture was inoculated into 1.2 L of culture medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture medium used in the bioreactor was BM3, a basal medium containing 0.07 mM sodium dextran sulfate, 4.8 mM uridine, and BM components (as shown in Table 7). The culture parameters were set as follows: rotation speed 210 rpm, temperature 37 °C, dissolved oxygen 35%, pH 7.0 ± 0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0076] (2) Feeding strategy: When the cell density reaches 4.0-6.0×10⁻⁶, 6 When the culture volume was 1000 cells / mL, the initial feeding was performed using a feeding medium containing 4.8 mM uridine and FM components (as shown in Table 9), with the initial feeding volume being 2% of the culture volume. Feeding was performed once daily, with the first four feedings at 2% of the culture volume, thereafter increasing the feeding volume to 3%. After the fourth feeding, the bioreactor rotation speed was increased to 420 rpm.
[0077] (3) Optimization of culture conditions: When the cell density reaches 2.0-2.4×10⁻⁶ 7When the cells / mL ratio was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0078] Step 4: End of Culture and Harvest: The culture was completed after 15 days of culture in the bioreactor, and the culture medium was harvested for subsequent analysis.
[0079] Sampling and testing frequency: The first sample was taken and the relevant indicators were tested 24 hours after inoculation, and then samples were taken and tested daily until the end of the culture.
[0080] Testing indicators:
[0081] Cell density and viability were detected using a cell counter.
[0082] The osmotic pressure of the culture was measured using an osmometer.
[0083] The concentration of lactic acid in the culture was detected using a biochemical analyzer;
[0084] The concentration of anti-PD-1 monoclonal antibody was determined by affinity chromatography purification.
[0085] The third objective of this invention is to provide a method for preparing CHO cells for producing anti-PD-1 monoclonal antibodies. The CHO cells used in this invention express a humanized anti-PD-1 antibody (Anti-PD-1-15C6D10-H), and the preparation process is as described in Example 5 of patent CN113372445A. The specific steps are as follows:
[0086] 1. Molecular construction of humanized antibody: The light and heavy chain complementarity-determining region (CDR) gene sequence of the mouse anti-PD-1 monoclonal antibody (patent CN113372445A from mouse hybridoma cell line: Anti-PD-1-15C6D10, accession number CGMCC No.19199) was linked to the human antibody framework region (CDR transplantation recipient) to complete the molecular construction of humanized antibody.
[0087] 2. Expression vector construction: The gene sequence of the above-mentioned humanized antibody was ligated into the expression vector pCHO1.0-PD-1-mFc, which contains the DHFR gene, and transformed into E. coli DH5α competent cells for amplification.
[0088] 3. CHO cell transfection and screening: The constructed expression vector was transfected into CHO cells, and the cells were screened using the DHFR system. After stepwise MTX compression, a CHO cell line stably expressing humanized anti-PD-1 antibody was obtained. This cell line was used as a working cell bank (WCB).
[0089] The anti-PD-1 monoclonal antibody of the present invention has a VL domain as shown in SEQ ID NO:1 and a VH domain as shown in SEQ ID NO:2.
[0090] DIVMTQSPDSLAVSAGERATINCRASQNIDNYIAWYQQKPGQPPKVLIYSASNRPSGVP DRFTGSGSGTDFTLTISSLQAEDVAVYYCQQNYNWPQTFGGGTKLEIK(SEQ ID NO: 1)
[0091] EVQLVQSGAEVKKPGATVKISCKASGYTFTDYYMHWVKQAPGKGLEWMARIDPWN NGHTKYDPKFQGRVTITLDTSTDIAYMELSSLRSEDTAVYYCARQQSRNWPRTWGQGTLVT VSS(SEQ ID NO: 2)
[0092] The technical solution of this invention has achieved beneficial technical effects: Through the above steps, this invention has achieved full-process optimization of CHO cell expression of anti-PD-1 monoclonal antibodies, effectively reducing the accumulation of metabolic byproducts, improving cell viability, and significantly improving the passage stability and antibody expression level of the cell bank. By optimizing the culture medium and culture process, this method is easy to implement and will not increase the research and development time and cost, providing reliable technical support for the large-scale industrial production of high-quality anti-PD-1 monoclonal antibodies. Detailed Implementation
[0093] The present invention will be further explained and described below with reference to the embodiments. It should be understood that the following embodiments are only used to illustrate the present invention and are not intended to limit the scope of protection of the present invention.
[0094] In the following embodiments, all materials used in the experiments can be purchased or prepared with reference to existing publicly available techniques; materials whose source and specifications are not specified are commercially available; and various processes and methods not described in detail are conventional methods known in the art.
[0095] Example 1: Preparation of CHO cells expressing anti-PD-1 monoclonal antibody
[0096] The present invention uses CHO cells to express humanized anti-PD-1 antibody (Anti-PD-1-15C6D10-H), and the specific steps are as follows:
[0097] 1. Molecular construction of humanized antibody: The light and heavy chain complementarity-determining region (CDR) gene sequence of the mouse anti-PD-1 monoclonal antibody (from the CN113372445A mouse hybridoma cell line: Anti-PD-1-15C6D10, accession number CGMCC No.19199) was linked to the framework region of the human antibody (CDR transplant recipient) to complete the molecular construction of the humanized antibody, and the VL domain with the amino acid sequence shown in SEQ ID NO:1 and the VH domain with the amino acid sequence shown in SEQ ID NO:2 were obtained.
[0098] DIVMTQSPDSLAVSAGERATINCRASQNIDNYIAWYQQKPGQPPKVLIYSASNRPSGVP DRFTGSGSGTDFTLTISSLQAEDVAVYYCQQNYNWPQTFGGGTKLEIK(SEQ ID NO: 1)
[0099] EVQLVQSGAEVKKPGATVKISCKASGYTFTDYYMHWVKQAPGKGLEWMARIDPWN NGHTKYDPKFQGRVTITLDTSTDIAYMELSSLRSEDTAVYYCARQQSRNWPRTWGQGTLVT VSS(SEQ ID NO: 2)
[0100] 2. Expression vector construction: The gene sequence of the above-mentioned humanized antibody was ligated into the expression vector pCHO1.0-PD-1-mFc, which contains the DHFR gene, and transformed into E. coli DH5α competent cells for amplification.
[0101] 3. CHO cell transfection and screening: The constructed expression vector was transfected into CHO cells, and the cells were screened using the DHFR system. After stepwise MTX-induced pressure screening, CHO cell lines that stably expressed humanized anti-PD-1 antibody were obtained and designated as WCB primary cells, which were then cryopreserved for later use.
[0102] Example 2
[0103] Provides WCB cells containing the target gene encoding an anti-PD-1 monoclonal antibody.
[0104] a. Resuscitation / passage / cryopreservation of primary WCB cells: Primary WCB cells were resuscitated, passaged, and cryopreserved using BM1 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM methotrexate (MTX), and BM components. Cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0105] b. Shake-flask amplification
[0106] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, 4.8 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, cell density 0.5 × 10⁻⁶. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0107] c. Cell culture in the bioreactor stage
[0108] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.07 mM sodium dextran sulfate, 4.8 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0109] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume was 1000 cells / mL, the initial feeding was performed using the feeding medium shown in Table 9, with the initial feeding volume being 2% of the culture volume. Feeding was performed once daily, with the first four feedings at 2% of the culture volume, and thereafter increasing the feeding volume to 3%. After the fourth feeding, the bioreactor rotation speed was increased to 420 rpm.
[0110] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0111] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 10.
[0112] Table 10 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0113]
[0114] In Example 2, the expression level of cells at passage 40 decreased by only 6.7% compared to WCB primary cells, and only by 17.4% at passage 60. Meanwhile, there were no significant changes in IVCD across passages, and the cell viability in Example 2 remained consistently above 95%, demonstrating remarkable stability. Through process optimization, Example 2 exhibited low total alkali consumption and low lactic acid accumulation, with osmotic pressure and lactic acid levels below 400 mOsm / kg and 20 mM, respectively, at passage 60, providing a favorable environment for cell growth and expression.
[0115] Example 3
[0116] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 0.05 mM sodium dextran sulfate and 0.0002 mM MTX and BM components; cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0117] b. Shake-flask amplification
[0118] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.05 mM sodium dextran sulfate, 0.0002 mM MTX, 2.0 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0119] c. Cell culture in the bioreactor stage
[0120] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.05 mM sodium dextran sulfate, 2.0 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0121] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6When the culture volume reaches 2% (cells / mL), the initial feeding should be performed using a feeding medium containing 2.0 mM uridine and FM components, with the initial feeding volume being 2% of the culture volume. Feeding should be performed once daily, with the first four feedings at 2% of the culture volume, thereafter increasing the feeding volume to 3%. After the fourth feeding, the bioreactor speed should be increased to 420 rpm.
[0122] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL concentration was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.00±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0123] End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. Culture stability data are shown in Table 11.
[0124] Table 11 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0125]
[0126] In Example 3, compared with the primary WCB cells, the antibody expression levels of the 20th, 40th, and 60th generations decreased by 1.9%, 8.0%, and 19.7%, respectively; the IVCD of the 60th generation cells increased by only 7.1% compared with WCB, and the cell viability of the 60th generation cells was around 95%; at the same time, the osmotic pressure of the 60th generation cells did not exceed 400 mOsm / kg, and the lactate was slightly greater than 20 mM, providing a favorable environment for cell growth and expression.
[0127] Example 4
[0128] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 0.1 mM sodium dextran sulfate and 0.0006 mM MTX and BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0129] b. Shake-flask amplification
[0130] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.1 mM sodium dextran sulfate, 0.0006 mM MTX, 8.0 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, and cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶.6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0131] c. Cell culture in the bioreactor stage
[0132] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.1 mM sodium dextran sulfate, 8.0 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0133] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using a feeding medium containing 8.0 mM uridine and FM components, with the initial feeding volume being 2% of the culture volume. Feeding should be performed once daily, with the first four feedings at 2% of the culture volume, thereafter increasing the feeding volume to 3%. After the fourth feeding, the bioreactor speed should be increased to 420 rpm.
[0134] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL concentration was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.00±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0135] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 12.
[0136] Table 12 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0137]
[0138] In Example 4, compared with the primary WCB cells, the antibody expression levels of the 20th, 40th, and 60th generations decreased by 1.1%, 7.4%, and 18.5%, respectively; the IVCD of the 60th generation cells increased by only 5% compared with WCB, and the viability of the 60th generation cells remained at approximately 95%; at the same time, the osmotic pressure of the 60th generation cells was also lower than 400 mOsm / kg, and the lactate was slightly higher than 20 mM, providing a favorable environment for cell growth and expression.
[0139] Example 5
[0140] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated, passaged, and cryopreserved using BM1 basal medium containing 0.03 mM sodium dextran sulfate and 0.00015 mM MTX and BM components. Cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0141] b. Shake-flask amplification
[0142] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.03 mM sodium dextran sulfate, 0.00015 mM MTX, 1.0 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, and cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0143] c. Cell culture in the bioreactor stage
[0144] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.03 mM sodium dextran sulfate, 1.0 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0145] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using a feeding medium containing 1.0 mM uridine and FM components, with the initial feeding volume being 2% of the culture volume. Feeding should be performed once daily, with the first four feedings at 2% of the culture volume, thereafter increasing the feeding volume to 3%. After the fourth feeding, the bioreactor speed should be increased to 420 rpm.
[0146] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7When the cells / mL concentration was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.00±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0147] c. End of Culture and Harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. Culture stability data are shown in Table 13.
[0148] Table 13 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0149]
[0150] In Example 5, compared to the primary WCB cells, the antibody expression levels at passages 20, 40, and 60 decreased by 7.0%, 15.4%, and 32.9%, respectively; the IVCD of passage 60 cells increased by 10.5% compared to WCB, and the cell viability at passage 40 was less than 95%; at passage 60, the osmotic pressure and lactate exceeded 400 mOsm / kg and 20 mM, respectively.
[0151] Example 6
[0152] a. CHO primary cell resuscitation, passage, and cryopreservation: CHO primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 0.15 mM sodium dextran sulfate and 0.0007 mM MTX and BM components. Cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0153] b. Shake-flask amplification
[0154] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.15 mM sodium dextran sulfate, 0.0007 mM MTX, 10.0 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, and cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0155] c. Cell culture in the bioreactor stage
[0156] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.15 mM sodium dextran sulfate, 10.0 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0157] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 10.0 mM uridine and FM components, the initial feeding should be performed using a feeding medium containing 10.0 mM uridine and FM components, with the initial feeding volume being 2% of the culture volume. Feeding should be performed once daily, with the first four feedings at 2% of the culture volume, thereafter increasing the feeding volume to 3%. After the fourth feeding, the bioreactor speed should be increased to 420 rpm.
[0158] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0159] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 14.
[0160] Table 14 Stability data of CHO cells producing anti-PD-1 monoclonal antibodies
[0161]
[0162] In Example 6, compared to primary WCB cells, antibody expression levels decreased by 6.8%, 12.2%, and 24.1% at passages 20, 40, and 60, respectively; IVCD of passage 60 cells increased by 5.1% compared to WCB, and cell viability at passage 40 was less than 95%; osmotic pressure and lactate levels at passage 60 exceeded 400 mOsm / kg and 20 mM, respectively.
[0163] Comparative Example 7
[0164] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated using BM1 resuscitation / passage / cryopreservation medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, and BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0165] b. Shake-flask amplification
[0166] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, 4.8 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, and cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0167] c. Cell culture in the bioreactor stage
[0168] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.07 mM sodium dextran sulfate, 4.8 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0169] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 3% (cells / mL), the initial feeding should be performed using the feeding medium shown in Table 8. The feeding method is to feed once a day, and the feeding volume is 3% of the culture volume.
[0170] Temperature, pH, and glucose concentration control: When cell density reaches 20-24 × 10⁻⁴ 6 When the cells / mL concentration was reached, the bioreactor temperature was lowered to 32℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0171] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 15.
[0172] Table 15 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0173]
[0174] In Comparative Example 7, compared to primary WCB cells, antibody expression levels decreased by 8.4%, 18.4%, and 40.9% at passages 20, 40, and 60, respectively. The IVCD of passage 60 cells increased by 13.8% compared to WCB cells, and the cell viability at passage 20 was less than 95%. The osmotic pressure and lactate at passage 40 exceeded 400 mOsm / kg and 20 mM, respectively.
[0175] Comparative Example 8
[0176] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 0.00025 mM MTX and BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0177] b. Shake-flask amplification
[0178] Shake-flask amplification: Cells were cultured in BM2 basal medium containing 0.00025 mM MTX and BM components in shake-flasks. The shaker settings were 120 rpm, 37°C, and 5% CO2 concentration. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁻⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 Bioreactor culture was performed at a concentration of cells / mL.
[0179] c. Bioreactor cultivation
[0180] Seed inoculation and initial culture: Bioreactor culture was conducted using BM3 basal medium containing BM components. 300 mL of the above-mentioned seeds were inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and a cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0181] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using the components shown in Table 16. Feeding should be done once daily at a volume of 3% of the culture volume.
[0182] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio is reached, the bioreactor temperature is lowered to 32℃, and the pH is controlled at 7.0±0.05. After feeding, a 2.78M glucose solution is used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0183] d. End of culture and harvest: The culture was terminated after 15 days of cultivation in the bioreactor, and the culture medium was harvested. The culture stability data are shown in Table 17.
[0184] Table 16
[0185] Components Concentration (mM) Components Concentration (mM) L-Aspartate, L-proline 40 24 L-glutamic acid 32 Phosphorylated L-tyrosine 16 L-Asparagine 40 L-valine 24 L-serine 40 L-methionine 11.2 L-glutamine 48 S-sulfo-L-cysteine 8 L-glycine 2.4 L-Isoleucine 24 L-histidine 8 L-Leucine 32 L-arginine 16 L-phenylalanine 8 L-threonine 24 L-Tryptophan 16 L-alanine 16 L-Lysine 32
[0186] Table 17 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0187]
[0188] In Comparative Example 8, compared to primary WCB cells, antibody expression levels decreased by 12.8%, 23.7%, and 54.0% at passages 20, 40, and 60, respectively; IVCD of passage 60 cells increased by 19.1% compared to WCB; cell viability was less than 95% at passage 20 and less than 90% at passage 60; and osmotic pressure and lactate levels at passage 20 exceeded 400 mOsm / kg and 20 mM, respectively.
[0189] Comparative Example 9
[0190] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / cryopreserved / passed using BM1 basal medium containing 0.07 mM sodium dextran sulfate and BM components. Cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0191] b. Shake-flask amplification
[0192] Shake-flask amplification: BM2 medium containing 0.07 mM sodium dextran sulfate and BM components was used for shake-flask amplification culture. The shaker settings were 120 rpm, 37°C, and 5% CO2 concentration. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁻⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 Bioreactor culture was performed at a concentration of cells / mL.
[0193] c. Cell culture in the bioreactor stage
[0194] Bioreactor culture was conducted using BM3 basal medium containing 0.07 mM sodium dextran sulfate and BM components. 300 mL of the above-mentioned seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and a cell density greater than 0.5 × 10⁻⁶. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0195] Feeding strategy: When cell density reaches 4-6 × 10⁻⁶ 6 The initial feeding was performed when the culture volume reached 3% (cells / mL), and the feeding medium used is shown in Table 16. Feeding was performed once daily at a volume of 3% of the culture volume.
[0196] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio is reached, the bioreactor temperature is lowered to 32℃, and the pH is controlled at 7.0±0.05. After feeding, a 2.78M glucose solution is used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0197] d. End of culture and harvest: The culture was terminated after 15 days of cultivation in the bioreactor, and the culture medium was harvested. The culture stability data are shown in Table 18.
[0198] Table 18 Stability data for anti-PD-1 monoclonal antibody production by CHO cells
[0199]
[0200] In Comparative Example 9, compared to primary WCB cells, antibody expression levels decreased by 15.1%, 25.4%, and 55.7% at passages 20, 40, and 60, respectively; IVCD of passage 60 cells increased by 19.5% compared to WCB; cell viability was less than 95% at passage 20 and less than 90% at passage 60; and osmotic pressure and lactate levels at passage 20 exceeded 400 mOsm / kg and 20 mM, respectively.
[0201] Comparative Example 10
[0202] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / cryopreserved / passed using BM1 basal medium containing only BM components. Cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0203] b. Shake-flask amplification
[0204] Shake-flask amplification: Cells were cultured in BM2 basal medium containing 4.8 mM uridine and BM components in shake flasks. The shaker settings were 120 rpm, 37°C, and 5% CO2 concentration. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁻⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 Bioreactor culture was performed at a concentration of cells / mL.
[0205] c. Bioreactor cultivation
[0206] Bioreactor culture was conducted using BM3 basal medium containing 4.8 mM uridine and BM. 300 mL of the above-mentioned seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and a cell density greater than 0.5 × 10⁻⁶. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0207] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using a feeding medium containing 4.8 mM uridine and the components shown in Table 16. Feeding should be done once daily at a volume of 3% of the culture volume.
[0208] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio is reached, the bioreactor temperature is lowered to 32℃, and the pH is controlled at 7.0±0.05. After feeding, a 2.78M glucose solution is used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0209] d. End of culture and harvest: The culture was terminated after 15 days of cultivation in the bioreactor, and the culture medium was harvested. The culture stability data are shown in Table 19.
[0210] Table 19 Stability data for anti-PD-1 monoclonal antibody production by CHO cells
[0211]
[0212] In Comparative Example 10, compared to the primary WCB cells, the antibody expression levels at passages 20, 40, and 60 decreased by 10.7%, 20.2%, and 45.9%, respectively. The IVCD of passage 60 cells increased by 14.0% compared to WCB. The cell viability at passage 20 was less than 95%, and at passage 60, the cell viability was less than 90%. The osmotic pressure and lactate at passage 20 exceeded 400 mOsm / kg and 20 mM, respectively.
[0213] Comparative Example 11
[0214] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 80.0 μM suramin, 0.0005 mM MTX, and BM. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0215] b. Shake-flask amplification
[0216] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 80.0 μM suramin, 0.0005 mM MTX, 1.0 mM cytidine, and BM. Culture conditions were: shaker speed 120 rpm, temperature 37℃, and carbon dioxide concentration 5%. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0217] c. Cell culture in the bioreactor stage
[0218] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 80.0 μM suramin, 1.0 mM cytidine, and BM. 300 mL of the above seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0219] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using a feeding medium containing 1.0 mM cytidine and FM components. The feeding method is to feed once a day, and the feeding volume is 3% of the culture volume.
[0220] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL concentration was reached, the bioreactor temperature was lowered to 32℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0221] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 20.
[0222] Table 20 Stability data for anti-PD-1 monoclonal antibody production by CHO cells
[0223]
[0224] In Comparative Example 11, compared with WCB primary cells, antibody expression levels decreased by 9.0%, 20.6%, and 44.9% at passages 20, 40, and 60, respectively. The IVCD of passage 60 cells increased by 14.2% compared with WCB, and cell viability at passage 20 was less than 95%. At passage 40, osmotic pressure and lactate exceeded 400 mOsm / kg and 20 mM, respectively.
[0225] Comparative Example 12
[0226] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, and BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0227] b. Shake-flask amplification
[0228] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.07 mM sodium dextran sulfate, 0.0005 mM MTX, 4.8 mM uridine, and BM. Culture conditions were: shaker speed 120 rpm, temperature 37℃, and carbon dioxide concentration 5%. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0229] c. Cell culture in the bioreactor stage
[0230] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.07 mM sodium dextran sulfate, 4.8 mM uridine, and BM. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0231] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 3% (cells / mL), the initial feeding is performed using a feeding medium with the components shown in Table 9. Feeding is done once a day at a rate of 3% of the culture volume. After the fourth feeding, the bioreactor speed is increased to 420 rpm.
[0232] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL concentration was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0233] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 21.
[0234] Table 21 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0235]
[0236] In Comparative Example 12, compared with WCB primary cells, antibody expression levels decreased by 7.3%, 16.2%, and 38.1% at passages 20, 40, and 60, respectively. IVCD of passage 60 cells increased by 12.3% compared with WCB, and cell viability at passage 20 was less than 95%. At passage 40, osmotic pressure and lactate exceeded 400 mOsm / kg and 20 mM, respectively.
[0237] Comparative Example 13
[0238] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated, passaged, and cryopreserved using BM1 basal medium containing 80.0 μM suramin, 0.0005 mM MTX, and BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0239] b. Shake-flask amplification
[0240] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 80.0 μM suramin, 0.0005 mM MTX, 4.8 mM uridine, and BM components. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, cell density 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0241] c. Cell culture in the bioreactor stage
[0242] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 80.0 μM suramin, 4.8 mM uridine, and BM components. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0243] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the cells / mL, the initial feeding was performed using the feeding medium with the components shown in Table 9. The feeding method was to feed once a day. The feeding volume for the first to fourth feedings was 2% of the culture volume, and the feeding volume thereafter was 3% of the culture volume. After the fourth feeding, the bioreactor speed was adjusted to 420 rpm.
[0244] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL concentration was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.00±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0245] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 22.
[0246] Table 22 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0247]
[0248] In Comparative Example 13, compared with WCB primary cells, antibody expression levels decreased by 5.7%, 15.4%, and 37.4% at passages 20, 40, and 60, respectively. The IVCD of passage 60 cells increased by 12.7% compared with WCB, and cell viability at passage 20 was less than 95%. At passage 40, osmotic pressure and lactate exceeded 400 mOsm / kg and 20 mM, respectively.
[0249] Comparative Example 14
[0250] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing 0.05 mM sodium dextran sulfate, 50.0 μM suramin, 0.0005 mM MTX, and BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0251] b. Shake-flask amplification
[0252] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM2 basal medium containing 0.05 mM sodium dextran sulfate, 50.0 μM suramin, 0.8 mM cytidine, 4.0 mM uridine, 0.0005 mM MTX, and BM. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, and cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0253] c. Cell culture in the bioreactor stage
[0254] Seed inoculation and initial culture: Cells were cultured in the bioreactor using BM3 basal medium containing 0.05 mM sodium dextran sulfate, 50.0 μM suramin, 0.8 mM cytidine, 4.0 mM uridine, and BM. 300 mL of the seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 210 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0255] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6When the cells / mL were at a certain level, the initial feeding was performed using a feeding medium containing 0.8 mM cytidine, 4.0 mM uridine, and FM. The feeding method was to feed once a day. The feeding volume for the first to fourth feedings was 2% of the culture volume, and the feeding volume thereafter was 3% of the culture volume. After the fourth feeding, the bioreactor speed was adjusted to 420 rpm.
[0256] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio was reached, the bioreactor temperature was lowered to 33℃, and the pH was strictly controlled at 7.0±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 33.3mM.
[0257] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 23.
[0258] Table 23 Stability data for anti-PD-1 monoclonal antibody production by CHO cells
[0259]
[0260] In Comparative Example 14, compared to primary WCB cells, antibody expression levels decreased by 5.2%, 12.9%, and 29.4% at passages 20, 40, and 60, respectively; IVCD of passage 60 cells increased by 10.0% compared to WCB, and cell viability at passage 40 was below 95%; at passage 60, osmolarity and lactate exceeded 400 mOsm / kg and 20 mM, respectively. The production process data shows that the experimental results of Example 14 were lower than those of Example 2, indicating that the additional addition of suramin and cytidine increased the metabolic stress on cells. Both uridine and cytidine phosphorylation depend on ATP; simultaneous supplementation under metabolic stress can lead to an imbalance in energy consumption. Furthermore, dextran sulfate is a polyanionic compound, while suramin is a polysulfate compound; when used simultaneously, the superposition or competition of charge regulation may disrupt the distribution of charge on the cell membrane surface, thus weakening the anti-aggregation effect.
[0261] Comparative Example 15
[0262] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM1 basal medium containing only BM components. Cells were passaged to passages 20, 40, and 60 for subsequent stability studies.
[0263] b. Shake-flask amplification
[0264] Shake-flask amplification: Shake-flask amplification was performed using BM2 basal medium containing only BM components. The shaker settings were 120 rpm, 37°C, and 5% CO2 concentration. The initial amplification volume was 30 mL, and the cell density was 0.5 × 10⁶ cells / mL. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 Bioreactor culture was performed at a concentration of cells / mL.
[0265] c. Bioreactor cultivation
[0266] Seed inoculation and initial culture: Bioreactor culture was conducted using BM3 basal medium containing only BM components. 300 mL of the above-mentioned seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and a cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.20, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0267] Feeding strategy: When cell density reaches 4.0-6.0 × 10⁻⁶ 6 When the culture volume reaches 1000 cells / mL, the initial feeding should be performed using the components shown in Table 16. Feeding should be done once daily at a volume of 3% of the culture volume.
[0268] Temperature, pH, and glucose concentration control: When cell density reaches 2.0-2.4 × 10⁻⁶ 7 When the cells / mL ratio is reached, the bioreactor temperature is lowered to 32℃, and the pH is controlled at 7.0±0.05. After feeding, a 2.78M glucose solution is used to maintain the glucose concentration in the culture at approximately 44.4mM.
[0269] d. End of culture and harvest: The culture was terminated after 15 days of cultivation in the bioreactor, and the culture medium was harvested. The culture stability data are shown in Table 24.
[0270] Table 24 Stability data of anti-PD-1 monoclonal antibody production by CHO cells
[0271]
[0272] In Comparative Example 15, compared to primary WCB cells, antibody expression levels decreased by 17.2%, 27.9%, and 56.7% at passages 20, 40, and 60, respectively; IVCD of passage 60 cells increased by 23.1% compared to WCB; cell viability was below 95% at passage 20 and below 90% at passage 40; and osmotic pressure and lactate levels at passage 20 exceeded 400 mOsm / kg and 20 mM, respectively.
[0273] Comparative Example 16
[0274] a. WCB primary cell resuscitation, passage, and cryopreservation: WCB primary cells were resuscitated / passaged / cryopreserved using BM component medium. Cells were passaged to the 20th, 40th, and 60th generations for subsequent stability studies.
[0275] b. Shake-flask amplification
[0276] Shake-flask amplification culture: Shake-flask amplification culture was performed using BM. Culture conditions were: shaker speed 120 rpm, temperature 37℃, carbon dioxide concentration 5%. Initial amplification volume was 30 mL, cell density 0.5 × 10⁻⁶. 6 The cells / mL were eventually expanded to 300 mL with a cell density greater than 2.5 × 10⁻⁶. 6 When the cell count reaches 1000 cells / mL, the cells are transferred to a bioreactor for further culture.
[0277] c. Cell culture in the bioreactor stage
[0278] Seed inoculation and initial culture: Culture was performed using a bioreactor with BM. 300 mL of the above seed culture was inoculated into 1.2 L of medium for fed-batch culture, with a final culture volume of 1.5 L and an initial cell density greater than 0.5 × 10⁻⁶ cells / mL. 6 The culture parameters were set as follows: rotation speed 420 rpm, temperature 37℃, dissolved oxygen 35%, pH 7.0±0.10, aeration rate 60 ccm. The pH was adjusted using carbon dioxide and sodium bicarbonate, and the dissolved oxygen was adjusted using pure oxygen.
[0279] Feeding strategy: When cell density reaches 5.0-7.0 × 10⁻⁶ 6 The initial feeding was performed when the culture volume reached 2% (cells / mL). The culture medium used is shown in Table 16. Feeding was performed once a day, with the initial feed volume being 2% of the culture volume, and subsequent feed volumes being 3% of the culture volume.
[0280] Temperature, pH, and glucose concentration control: When cell density reaches 16-18 × 10⁻⁶ 6When the cells / mL ratio was reached, the bioreactor temperature was lowered to 32℃, and the pH was strictly controlled at 6.90±0.05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at approximately 22.2mM.
[0281] d. End of culture and harvest: The culture was terminated after 15 days in the bioreactor, and the culture medium was harvested for subsequent analysis. The culture stability data are shown in Table 25.
[0282] Table 25 shows the stability data for anti-PD-1 monoclonal antibody production by CHO cells.
[0283]
[0284] In Comparative Example 16, compared to primary WCB cells, antibody expression levels decreased by 18.6%, 31.0%, and 57.5% at passages 20, 40, and 60, respectively; IVCD of passage 60 cells increased by 25.9% compared to WCB; cell viability was below 95% at passage 20 and below 90% at passage 40; and osmotic pressure and lactate exceeded 400 mOsm / kg and 20 mM, respectively, at passage 20.
Claims
1. A culture medium for producing anti-PD-1 antibodies, characterized in that, The culture medium comprises basal culture medium BM1, basal culture medium BM2, basal culture medium BM3 and supplemental culture medium, wherein the culture medium contains one or more of MTX, sodium dextran sulfate, and uridine.
2. The culture medium according to claim 1, characterized in that, The culture medium contains 0.0002-0.0006 mM of MTX.
3. The culture medium according to claim 1, characterized in that, The culture medium contains 0.05-0.1 mM sodium dextran sulfate.
4. The culture medium according to claim 1, characterized in that, The culture medium contains 2.0-8.0 mM uridine.
5. A method for producing anti-PD-1 antibody using the culture medium of claim 1, characterized in that, Includes the following steps: (a) Provide CHO cells containing the target gene encoding an anti-PD-1 antibody; (b) Resuscitate / passage / freeze the CHO cells obtained in step (a) using the basal culture medium BM1 described in claim 1; (c) Shake-flask amplification culture was carried out in basal medium BM2; (d) Cell culture in the bioreactor stage in basal medium BM3; (e) End of training and harvest.
6. The method for producing anti-PD-1 antibody according to claim 5, characterized in that, The cell culture process in the bioreactor stage includes the following steps: (1) Seed inoculation and initial culture; (2) Feeding stage; (3) Optimization of cultivation conditions.
7. The method for producing anti-PD-1 antibody according to claim 6, characterized in that, The seed inoculation and initial culture involve inoculating the seed solution into a culture medium for fed-batch culture.
8. The method for producing anti-PD-1 antibody according to claim 6, characterized in that, The specific feeding method is as follows: when the cell density reaches 4.0-6.0 × 10⁻⁶. 6 When the cells / mL, the feeding medium described in claim 1 is used for the first feeding, and the feeding method is to feed once a day. The feeding amount for the first to fourth feedings is 2% of the culture volume, and then the feeding amount is increased to 3%. After the fourth feeding, the bioreactor speed is increased to 420 rpm.
9. The method for producing anti-PD-1 antibody according to claim 6, characterized in that, The optimized culture conditions are achieved when the cell density reaches 2.0-2.4 × 10⁻⁶. 7 When the cells / mL ratio was reached, the bioreactor temperature was lowered to 33℃ and the pH was strictly controlled at 7.0±0.
05. During the feeding process, a 2.78M glucose solution was used to maintain the glucose concentration in the culture at around 33.3mM.
Citation Information
Patent Citations
Anti-PD-1 monoclonal antibody
CN113372445A
